| Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma A Murumägi, D Ungureanu, S Khan, M Arjama, K Välimäki, A Ianevski, ... British Journal of Cancer 128 (4), 678-690, 2023 | 12 | 2023 |
| New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactome J Raivola, A Dini, K Salokas, H Karvonen, W Niininen, E Piki, M Varjosalo, ... Cellular and Molecular Life Sciences 79 (5), 276, 2022 | 6 | 2022 |
| Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic intervention J Raivola, A Dini, H Karvonen, E Piki, K Salokas, W Niininen, L Kaleva, ... Cell Death & Disease 13 (8), 714, 2022 | 4 | 2022 |
| ROR1-STAT3 signaling contributes to ovarian cancer intra-tumor heterogeneity E Piki, A Dini, J Raivola, K Salokas, K Zhang, M Varjosalo, T Pellinen, ... Cell Death Discovery 9 (1), 222, 2023 | 2 | 2023 |
